Sign In
Buy ELAN
$23.89
-0.330 (-1.36%)
At Close: Jun 22, 2026
7 Pharmaceutical Stocks With Exciting Plans for 2021
02:51pm, Wednesday, 13'th Jan 2021
Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.
Elanco Animal Health Incorporated (ELAN) CEO Jeffrey Simmons Presents at 39th Annual JPMorgan Virtual Healthcare Brokers Conference (Transcript)
Elanco Begins Next Phase of Integration Post-Bayer Animal Health Acquisition; Executive Committee Member Sarena Lin to Depart
07:00am, Monday, 11'th Jan 2021
GREENFIELD, Ind.--(BUSINESS WIRE)--Today Elanco Animal Health Incorporated (NYSE: ELAN) announced that executive vice president of Transformation and Technology, Sarena Lin, will take a role outside o
4 Top Stock Trades for Friday: Bitcoin, WBA, ELAN, GRMN
05:13pm, Thursday, 07'th Jan 2021
Bitcoin, Walgreens, Elanco Animal Health and Garmin were our top stock trades for Thursday. Let's have a look at what the charts are saying.
Elanco Animal Health: Investor Day Highlights Path Toward Closing The Valuation Gap
03:12pm, Sunday, 03'rd Jan 2021
Elanco outlined its latest financial targets at a recent investor day event. The innovation engine is in full swing, and if it delivers, I see plenty of upside to the conservative top-line targets.
Elanco to Participate in the 39th Annual J.P. Morgan Healthcare Conference
08:30am, Tuesday, 22'nd Dec 2020
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021. Jeff Simmons, pres
3 Stocks to Profit From the Pet Economy
12:20pm, Saturday, 19'th Dec 2020
Spending on pets is a $100 billion industry. Here's how you can take advantage.
Elanco Animal Health Hosts Investor Day, Demonstrating Inflection Point Toward Accelerated Value Creation
08:00am, Tuesday, 15'th Dec 2020
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today will host its Investor Day, where the executive leadership team will outline the company's strengthened and expa
Elanco Appoints New Independent Directors to the Board and Expands Innovation and Operational Oversight
04:05pm, Monday, 14'th Dec 2020
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it has appointed distinguished healthcare executive, animal health director and investor William
Elanco Announces Agreement with KindredBio to Bring First-of-its-Kind Canine Parvovirus Therapy to Market
08:00am, Friday, 11'th Dec 2020
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced an agreement with Kindred Biosciences (NASDAQ: KIN) to acquire exclusive global rights to KIND-030, a
Elanco Animal Health Selects Indiana as Home for Global HQ and Future Footprint Consolidation
07:30am, Friday, 04'th Dec 2020
GREENFIELD, Ind.--(BUSINESS WIRE)--After a rigorous multi-state search, Elanco Animal Health, Inc. (NYSE: ELAN) today announced Indiana as its base for future global consolidated operations, anchored
Elanco Animal Health, Inc. (ELAN) Presents at Evercore ISI HealthCONx Broker Conference Call - (Transcript)
06:54pm, Tuesday, 01'st Dec 2020
Elanco Animal Health, Inc. (ELAN) Presents at Evercore ISI HealthCONx Broker Conference Call - (Transcript)
Elanco to Host Virtual Investor Day, Provide 2021 Guidance
08:30am, Tuesday, 01'st Dec 2020
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it will host a virtual investor day on Tuesday, December 15, 2020. The event will feature present
Bayer Sells $1.6B Stake In Elanco Animal Health
04:34am, Tuesday, 01'st Dec 2020
Elanco Animal Health Inc (NYSE: ELAN) in a filing with the U.S. Securities and Exchange Commission on Monday disclosed that German pharma and life sciences company Bayer AG (OTC: BAYRY) is offloading
Elanco Announces Pricing of Public Offering of Common Stock by Selling Shareholder
10:00pm, Monday, 30'th Nov 2020
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced the pricing of the previously announced public offering of 54,500,000 shares of its common stock held
